Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Institute of Liver Studies, MowatLabs, Department of Inflammation Biology, School of Immunology & Microbial Sciences, Faculty of Liver Sciences and Medicine, King's College London, London, United Kingdom.
J Autoimmun. 2021 May;119:102619. doi: 10.1016/j.jaut.2021.102619. Epub 2021 Feb 27.
Regulatory T-cells (Tregs) are key players in the maintenance of immune homeostasis by preventing immune responses to self-antigens. Defects in Treg frequency and/or function result in overwhelming CD4 and CD8 T cell immune responses participating in the autoimmune attack. Perpetuation of autoimmune damage is also favored by Treg predisposition to acquire effector cell features upon exposure to a proinflammatory challenge. Treg impairment plays a permissive role in the initiation and perpetuation of autoimmune liver diseases, namely autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. In this Review, we outline studies reporting the role of Treg impairment in the pathogenesis of these conditions and discuss methods to restore Treg number and function either by generation/expansion in the test tube or through in vivo expansion upon administration of low dose IL-2. Challenges and caveats of these potential therapeutic strategies are also reviewed and discussed.
调节性 T 细胞(Tregs)通过防止针对自身抗原的免疫反应,在维持免疫稳态方面发挥着关键作用。Treg 频率和/或功能的缺陷会导致 CD4 和 CD8 T 细胞免疫反应失控,从而参与自身免疫攻击。Treg 易于在受到促炎挑战时获得效应细胞特征,这也有利于自身免疫损伤的持续存在。Treg 功能障碍在自身免疫性肝病(即自身免疫性肝炎、原发性胆汁性胆管炎和原发性硬化性胆管炎)的发生和持续中起着许可作用。在这篇综述中,我们概述了报告 Treg 功能障碍在这些疾病发病机制中作用的研究,并讨论了通过在试管中生成/扩增或通过低剂量 IL-2 给药进行体内扩增来恢复 Treg 数量和功能的方法。还回顾和讨论了这些潜在治疗策略的挑战和注意事项。